Cargando…
Identification of 5-Iodotubercidin as a Genotoxic Drug with Anti-Cancer Potential
Tumor suppressor p53, which is activated by various stress and oncogene activation, is a target for anti-cancer drug development. In this study, by screening panels of protein kinase inhibitors and protein phosphatase inhibitors, we identified 5-Iodotubercidin as a strong p53 activator. 5-Iodotuberc...
Autores principales: | Zhang, Xin, Jia, Deyong, Liu, Huijuan, Zhu, Na, Zhang, Wei, Feng, Jun, Yin, Jun, Hao, Bin, Cui, Daxiang, Deng, Yuezhen, Xie, Dong, He, Lin, Li, Baojie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3646850/ https://www.ncbi.nlm.nih.gov/pubmed/23667485 http://dx.doi.org/10.1371/journal.pone.0062527 |
Ejemplares similares
-
5-Iodotubercidin inhibits SARS-CoV-2 RNA synthesis
por: Zhao, Jianyuan, et al.
Publicado: (2022) -
Haspin-dependent and independent effects of the kinase inhibitor 5-Iodotubercidin on self-renewal and differentiation
por: Karanika, Eleftheria, et al.
Publicado: (2020) -
5-Iodotubercidin sensitizes cells to RIPK1-dependent necroptosis by interfering with NFκB signaling
por: Chauhan, Chanchal, et al.
Publicado: (2023) -
Identification of Bisindolylmaleimide IX as a potential agent to treat drug-resistant BCR-ABL positive leukemia
por: Zhang, Xin, et al.
Publicado: (2016) -
Identification of Volatile Biomarkers of Gastric Cancer Cells and Ultrasensitive Electrochemical Detection based on Sensing Interface of Au-Ag Alloy coated MWCNTs
por: Zhang, Yixia, et al.
Publicado: (2014)